Guess three strong risers on the Helsinki Stock Exchange next year. You have until December 31, 2019 to answer. I’ll throw in Kamux, Noho, and Wärtsilä.
4 Likes
Let’s take a risky tactic instead of the safe tactic from 2019.
Herantis Pharma, Enersense, and Basware.
With the 2019 picks, Talenom, Qt, and Remedy probably did reasonably well, right?
I stuck to the domestic stock market. And all of them are in my own portfolio.
By when do we lock it in?
1 Like
My guess:
Relais Group, Taaleri and Wärre
3 Likes
Taaleri, Basware and Wärtsilä.
At least I hope so 
QT, NoHo and Robit.
Uncle Masse, FA, smells the masses once again 
2 Likes
Update 31.12.: Remedy / Glaston / Qt.
I reserve the right to make changes until 31.12. 
1 Like
Fodelia, Kamux, Revenio.
Efecte, Remedy, and Revenio
2 Likes
My combo: Noho, Kamux and Relais Group
Efecte, Remedy, and Kamux 
1 Like
NoHo, Exel, and QPR
In the previous and past years, I’ve thrown my standard bets on Shareville for Revenio, and it hit well this year at least.
For next year, Remedy (already a rough undervaluation! Even if Control flops in sales), Rovio (based on something completely different than the AB brand), Marimekko (brand rocketing and being bought out, still a significant discount compared to peers).
Actually, all eight stocks in my portfolio would be on the list due to sales speculation, but I decided to rationalize it based on other reasons as well.
From under the radar, as dark horses from the promised land of duopolies and monopolies, I’ll add Terveystalo.
It’s also based on a Lynch-like boots-on-the-ground approach, that even private services won’t be enough for the sick in this country for much longer. 
NoHo, relais group and fellow finance
Qt / Remedy / Nokia
QPR, Relais Group and Exel
Remedy, Fodelia, and Capman
Wärre, Basware, and Revenio.
Qt, revenio, exel
1 Like
Relais Group, Fodelia, Nokia
Qt, relay and noho